About Citizenplus Pharmaceuticals Private Limited
Data last updated:
Citizenplus Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2015PTC098583. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.93 Cr. It is led by directors Sreehari Kumar Annamraju (Managing Director) and Venkata Radh Krishna Kishore Annamraju.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Ff5 Fourth Floor Empire Square Road No.36, Hyderabad, Telangana, India – 500033.
As per the financials filed for FY 2022, the company reported a revenue of ₹15.21 Cr, a growth of 116% compared to the previous year. For the same year it recorded a net profit of ₹19.11 Lakh (net margin 1.3%) and EBITDA of ₹41.76 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 674% over three years.
The company has about 26 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Citizenplus Pharmaceuticals. As per MCA filings, the company has open charges of ₹95 Lakh on record. Court records list 27 cases involving the company, including 27 filed against it; 14 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website citizenplus.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressFf5 Fourth Floor Empire Square Road No.36, Hyderabad, Telangana, India – 500033
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Citizenplus Pharmaceuticals Private Limited
The main business activity of Citizenplus Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Citizenplus Pharmaceuticals Private Limited FY 2022 filings available
Citizenplus Pharmaceuticals Private Limited reported revenue of ₹15.21 Cr (up 116% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Citizenplus Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 674% over three years, including 116% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Citizenplus Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹15.21 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹41.76 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹19.11 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Citizenplus Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Citizenplus Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Citizenplus Pharmaceuticals Private Limited
Citizenplus Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stanmark Healthcare Private Limited | ₹15.31 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Ahmedabad, Gujarat, India |
| Vilin Bio Med Limited | ₹15.28 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Hyderabad, Telangana, India |
| Ishita Active Pharma Ingredients Private Limited | ₹15.25 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Ahmedabad, Gujarat, India |
| Bymaa Laboratories Private Limited | ₹15.25 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Puducherry, India |
| Saviour Caps Private Limited | ₹15.24 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Bhopal, Madhya Pradesh, India |
| Citizenplus Pharmaceuticals Private Limited this company | ₹15.21 Cr (FY 2022) | •••• | •••• | 116.0% | •••• | Hyderabad, Telangana, India |
| DVR Pharma LLP | ₹15.2 Cr (FY 2021) | •••• | •••• | 94.0% | •••• | Nalgonda, Telangana, India |
| SH Pharmaceuticals Limited | ₹15.2 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Hyderabad, Telangana, India |
| National Capsules Private Limited | ₹15.19 Cr (FY 2024) | •••• | •••• | -39.0% | •••• | Vidisha, Madhya Pradesh, India |
| Shiv Shakti Pharma Care Private Limited | ₹15.19 Cr (FY 2025) | •••• | •••• | -49.0% | •••• | Vapi, Gujarat, India |
| Nicosia Biolabs International Private Limited | ₹15.16 Cr (FY 2024) | •••• | •••• | 66.0% | •••• | Ludhiana, Punjab, India |
Peers are the five companies nearest above and the five nearest below Citizenplus Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Citizenplus Pharmaceuticals Private Limited
Citizenplus Pharmaceuticals Private Limited is audited by G S MADHAVA RAO & Co. for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G S MADHAVA RAO & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Citizenplus Pharmaceuticals Private Limited
Citizenplus Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sreehari Kumar Annamraju Also directs: Annamraju Infra Private Limited, Saradyuthi Likhita Broadcasting Private Limited, Lexaro Laboratories Private Limited and 1 more | Managing Director | 19 Nov 2019 | 6 Years 10 Months | Current |
| Venkata Radh Krishna Kishore Annamraju | Director | 22 Apr 2015 | 11 Years 5 Months | Current |
Ownership and Shareholding of Citizenplus Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Citizenplus Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Dec 2021 | Others | ₹95 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Citizenplus Pharmaceuticals Private Limited
Citizenplus Pharmaceuticals Private Limited has 27 court cases on record: 27 filed against it. 14 cases are pending and 13 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 25 | 25 | 13 |
| High courts | 2 | 2 | 1 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Court case (CC.NI) | Filed against the company by Tagoor Laboratories Private Limited | Pending |
| District court, Hyderabad CCC, Telangana | Court case (COS) | Filed against the company by Saraca Laboratories Limited | Pending |
| Calcutta High Court | Court case (EC-COM) | Filed against the company by L & T Finance Limited | Pending |
| District court, Chennai, Tamil Nadu | Criminal case | Filed against the company by Indusind Bank Ltd. | Pending |
| District court, Meerut, Uttar Pradesh | Criminal case | Filed against the company by Mahindra and Mahindra Financial Services Limited | Pending |
Full case history
All 27 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Citizenplus Pharmaceuticals Private Limited
Citizenplus Pharmaceuticals operates one associated brand: Citizenplus Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pellets and granules for healthcare industry globally. | citizenplus.in |
Employees and EPFO Compliance at Citizenplus Pharmaceuticals Private Limited
Citizenplus Pharmaceuticals Private Limited has a workforce of 26 employees as of Jun 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Citizenplus Pharmaceuticals Private Limited
Citizenplus Pharmaceuticals has one previous CIN (Corporate Identification Number): U45100TG2015PTC098583. The current CIN is U24100TG2015PTC098583, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2015PTC098583 | Current |
| U45100TG2015PTC098583 | Previous |
Recent Activity on Citizenplus Pharmaceuticals Private Limited
Citizenplus Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Bala Venkata Reddy Turpuseema ceased to be Director on 02 Apr 2025.
Credit Ratings, Litigation & Regulatory Alerts for Citizenplus Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Citizenplus Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Citizenplus Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Citizenplus Pharmaceuticals Private Limited
Citizenplus Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Citizenplus Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Citizenplus Pharmaceuticals Private Limited
Citizenplus Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 April 2015 (11+ years old) and is registered under CIN U24100TG2015PTC098583.
Citizenplus Pharmaceuticals reported revenue of ₹15.21 Cr for FY 2022 (up 116% YoY).
Citizenplus Pharmaceuticals has 2 current directors:
- Sreehari Kumar Annamraju - Managing Director
- Venkata Radh Krishna Kishore Annamraju - Director
Citizenplus Pharmaceuticals reported a net profit of ₹19.11 Lakh (net margin 1.3%) and EBITDA of ₹41.76 Lakh (EBITDA margin 2.7%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Citizenplus Pharmaceuticals is 674% over three years. In the latest year (FY 2022) revenue rose 116%. CAGR is the steady yearly rate that links the first and the last year.
No. Citizenplus Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Citizenplus Pharmaceuticals is U24100TG2015PTC098583. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Citizenplus Pharmaceuticals has 27 court cases on record: 27 filed against it. 14 are pending. Most are in the district courts.
Citizenplus Pharmaceuticals was incorporated on 22 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Citizenplus Pharmaceuticals by revenue are Stanmark Healthcare Private Limited, Vilin Bio Med Limited, Ishita Active Pharma Ingredients Private Limited, Bymaa Laboratories Private Limited, Saviour Caps Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Bala Venkata Reddy Turpuseema ceased to be Director on 02 Apr 2025. Aparna Annamaraju ceased to be Director on 10 Nov 2021. Sreehari Kumar Annamraju ceased to be Additional Director on 27 May 2020. Citizenplus Pharmaceuticals has 5 board changes on record in total.